astrazenecaLatest daily volume: 12,074 (as of 2026-05-15) · Locale: EN-US
Topic groups: Healthcare & Pharmaceuticals
Figures are computed from our daily Google search volume time series. API access is available for subscribers.
AstraZeneca attracts sustained interest in the United States. Current daily demand is 12,074, with an average monthly volume of 474,046. Our dataset updates continuously, with the most recent daily datapoint on 2026-05-15. Marketers, investors, and analysts use this ultra-granular visibility to anticipate news-driven and seasonal spikes across channels, campaigns, and portfolios effectively.
AstraZeneca So Popular?AstraZeneca is a British–Swedish multinational biopharmaceutical company known for developing and commercializing prescription medicines across oncology, cardiovascular, renal & metabolism, and respiratory & immunology. In search, the term spans multiple contexts: the company, its medicines (e.g., Tagrisso, Farxiga, Imfinzi, Symbicort/FluMist), investor information (ticker AZN), careers, and patient support.
Popularity persists because major pharma brands generate continuous news flow (approvals, trial readouts, pricing, access changes) and broad consumer relevance across multiple therapeutic areas.
The baseline interest for AstraZeneca is high and persistent, reflected in a six-figure average monthly volume, with day-to-day movement in the mid-to-high thousands on typical days. Volumes commonly spike around news cycles and seasonal moments tied to respiratory products and public-health campaigns.
Taken together, these patterns produce recurring peaks over a durable baseline, making daily resolution essential for separating transient spikes from structural trend shifts.
Daily search volumes help you time actions, calibrate messaging, and measure real-world interest with near-real-time fidelity. Use the day-level granularity to align budgets, content, and risk decisions to market attention.
AstraZeneca’s daily interest vs. peers to contextualize sentiment.